
Inflammation — the anti-inflammatory supplement shelf
Anti-inflammatory supplements 2026 — curcumin, omega-3, tart cherry, boswellia and the CRP claim, reviewed
'Chronic inflammation' is the most-invoked and least-measured word in wellness. Eight of the most-sold anti-inflammatory supplements of 2026, ranked by bioavailability, the actual marker they move, and whether the trial that made the claim used a dose anyone can buy
Inflammation sells because it explains everything and commits to nothing. Fatigue, joint pain, brain fog, weight that will not move, skin that flares — all of it gets routed to 'chronic low-grade inflammation', and the shelf is happy to supply a capsule. The physiology is real: persistent low-grade elevation in IL-6, TNF-α and CRP is genuinely associated with cardiometabolic and neuropsychiatric outcomes across large cohorts, and inflammation-induced sickness behaviour is one of the better-described mechanisms linking immune activation to low mood and fatigue (Dantzer; Miller & Raison). What is far less certain is that a supplement moves those markers meaningfully in a free-living person, at a dose sold on Amazon, in a body that sleeps six hours and sits for eleven. Two ingredients on this shelf have serious human data. The rest range from promising to decorative.














































